JB Pharma Advocates Renewable Energy for Growth

25 Oct 2024 CW Team

JB Pharma has underscored the critical importance of adopting renewable energy sources to meet its future energy needs and support sustainability initiatives. The pharmaceutical company recognizes that transitioning to clean energy is not just a responsibility but a strategic move to enhance its operational efficiency and reduce its environmental impact.

As JB Pharma seeks to align its manufacturing processes with sustainable practices, the company is actively exploring various renewable energy solutions. This transition is expected to significantly decrease its carbon footprint, contributing to global efforts against climate change while also fostering a more resilient supply chain.

The management emphasizes that investing in renewable energy sources will lead to cost efficiency in the long run. By leveraging solar, wind, and other renewable options, JB Pharma aims to secure energy for its operations while adhering to stringent environmental standards. This commitment reflects a broader industry trend toward energy transition, where companies recognize the necessity of integrating eco-friendly practices into their business models.

JB Pharma's proactive approach highlights the growing recognition among pharmaceutical firms of the need for energy security and regulatory compliance. The company is keen on collaborating with stakeholders and industry partners to promote innovation in energy solutions and drive the adoption of green initiatives across the sector.

By committing to renewable energy, JB Pharma not only supports its growth ambitions but also demonstrates its dedication to corporate responsibility and sustainable development. This strategy positions the company as a leader in the industry, prepared to navigate the challenges and opportunities of a rapidly changing energy landscape while ensuring a positive impact on the environment.

Infrastructure Urban

06 Nov 2025

Concord Control Systems Limited Reports ~85% YoY Growth in H1 FY26

Concord Control Systems Limited (BSE: CNCRD | 543619), India’s leading manufacturer of embedded electronic systems and critical electronic solutions, announced its unaudited financial results for the half year ended September 30, 2025.Financial Highlights – H1 FY26 (YoY Comparison)Revenue from Operations rose to ₹815.45 million, up from ₹497.53 million in H1 FY25, marking a 63.90% year-on-year growth.EBITDA increased to ₹217.34 million, compared to ₹142 million in the same period last year.EBITDA Margin stood at 26.65%, compared to 28.54% in H1 FY25, with the decline attributed to ..

Gateway Distriparks Announces Q2 FY25 Results

Gateway Distriparks Limited (GDL), one of India’s leading multimodal logistics providers, announced its financial results for the quarter ended 30 September 2025.For Q2, the company reported total revenue of INR 154.8 crore (H1: INR 316.9 crore), EBITDA of INR 20.56 crore (H1: INR 45.65 crore), PBT of INR –4.23 crore (H1: INR –0.28 crore), and PAT of INR –2.91 crore (H1: INR –0.37 crore). The company stated that these numbers reflect the consolidation of accounts following Snowman Logistics transitioning from an associate company to a subsidiary in December 2024.Commenting on the per..

Last-Mile Connectivity a Prime Focus, Says Ms. Ashwini Bhide,

The IMC Chamber of Commerce and Industry (IMC) hosted a high-impact Managing Committee session today on the theme “Mumbai Metro: Transforming Connectivity and Commuting.” The session featured an insightful address by Ms. Ashwini Bhide, Managing Director, Mumbai Metro Rail Corporation Ltd. (MMRCL), who shared updates on key transport infrastructure developments across Mumbai and the MMR region.Emphasising the city’s critical economic role, Ms. Bhide noted, “Mumbai is the economic powerhouse of Maharashtra, with more than 95% of the region’s population living in urban areas. As Maharas..